论文部分内容阅读
Introduction Few clinical trials were conducted to compare the efficacy and safety of unrelated cord blood transplantation (CBT) and HLA-matched sibling allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with chronic myeloid leukemia (CML) in advanced stage (accelerated phase or blast crisis).